Extended-release tablets of alfuzosin hydrochloride for benign prostatic hyperplasia management. Produced by urology-focused pharmaceutical suppliers and provided to community pharmacies and urology clinics. Sourced by medical professionals for outpatient treatment in male patients over 50.